Dr. Serrao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5300 Far Hills Ave
Ste 300
Dayton, OH 45429Phone+1 937-433-7536Fax+1 937-433-9612
Education & Training
Wright State UniversityResidency, Dermatology, 2009 - 2012
Kettering Health Network/Kettering Medical CenterInternship, Transitional Year, 2008 - 2009
University of Pittsburgh School of MedicineClass of 2008
Certifications & Licensure
OH State Medical License 2008 - 2026
American Board of Dermatology Dermatology
Clinical Trials
- A Phase II Study in Patients With Alopecia Areata Start of enrollment: 2020 May 13
Publications & Presentations
PubMed
- Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Rand...Lawrence F Eichenfield, Rocco Serrao, Vimal H Prajapati, John C Browning, Lisa Swanson
Pediatric Dermatology. 2025-02-20 - Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children.Eric L Simpson, Adelaide A Hebert, John Browning, Rocco T Serrao, Howard Sofen
Dermatology and Therapy. 2025-01-01 - 2 citationsLong-Term Efficacy of Dupilumab in Alopecia Areata.Maansi Kulkarni, Craig A Rohan, Jeffrey B Travers, Rocco Serrao
The American Journal of Case Reports. 2022-06-21
Professional Memberships
- Associate
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
